BOOK
New Perspectives in Infectious Diseases, An Issue of Veterinary Clinics of North America: Equine Practice, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue focuses on the latest approach to infectious diseases and covers topics such as: Salmonellosis, Lawsonia intracellularis, Strangles, Rhodococcus equi, Equine Herpesvirus-1, Equine Influenza Virus, Equine Arteritis Virus, West Nile Virus and Equine Encephalitis Viruses, Equine Infectious Anemia Virus, and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| New Perspectives inInfectious Diseases | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| Contents | vii | ||
| Veterinary Clinics Of\rNorth America: Equine Practice | xi | ||
| Foreword\r | xiii | ||
| Preface\r | xv | ||
| Equine Herpesvirus 1 Myeloencephalopathy | 489 | ||
| Key points | 489 | ||
| Introduction | 490 | ||
| Etiology | 490 | ||
| Epidemiology | 491 | ||
| Pathogenesis | 492 | ||
| Clinical signs | 494 | ||
| Respiratory Disease | 494 | ||
| Abortion | 495 | ||
| Equine Herpesvirus Myeloencephalopathy | 495 | ||
| Equine Herpesvirus 1 Chorioretinopathy | 497 | ||
| Diagnosis | 497 | ||
| Cell Blood Count | 497 | ||
| Cerebrospinal Fluid Analysis | 497 | ||
| Virus Isolation and Detection | 497 | ||
| Polymerase Chain Reaction Testing | 497 | ||
| Serologic Analysis | 499 | ||
| Histopathologic Examination | 499 | ||
| Therapeutic strategies | 499 | ||
| Immunity and immune evasion | 501 | ||
| Immunity to Equine Herpesvirus 1 | 501 | ||
| Immune Evasion by Equine Herpesvirus 1 | 501 | ||
| Control strategies | 502 | ||
| Summary | 504 | ||
| References | 504 | ||
| Equine Influenza Virus | 507 | ||
| Key points | 507 | ||
| Introduction | 507 | ||
| Etiology | 508 | ||
| Genetic diversity of influenza A virus | 509 | ||
| Evolution of Equine Influenza Virus and Vaccine Composition | 510 | ||
| Cross-Species Transmission of Equine Influenza | 510 | ||
| Epidemiology | 511 | ||
| Recent equine influenza outbreaks | 512 | ||
| Pathogenesis and clinical disease | 513 | ||
| Diagnosis | 514 | ||
| Virus Isolation | 514 | ||
| Antigen Detection | 514 | ||
| Reverse Transcription–Polymerase Chain Reaction Analysis | 514 | ||
| Antibody Detection | 515 | ||
| Control | 516 | ||
| Summary | 516 | ||
| References | 517 | ||
| West Nile Virus and Equine Encephalitis Viruses | 523 | ||
| Key points | 523 | ||
| Eastern equine encephalitis | 523 | ||
| Etiology | 523 | ||
| Epidemiology | 525 | ||
| Clinical Signs | 525 | ||
| Diagnosis | 525 | ||
| Pathologic Findings | 527 | ||
| Therapeutic Strategies | 528 | ||
| Control Strategies | 529 | ||
| Western equine encephalomyelitis | 529 | ||
| Etiology and Epidemiology | 529 | ||
| Clinical Signs | 529 | ||
| Diagnosis | 529 | ||
| Treatment | 529 | ||
| Equine Viral Arteritis | 543 | ||
| Key points | 543 | ||
| Virus | 543 | ||
| Clinical signs | 544 | ||
| Epidemiology | 547 | ||
| Pathogenesis and pathologic condition | 548 | ||
| Immune response | 549 | ||
| Diagnosis | 549 | ||
| Treatment | 550 | ||
| Vaccination | 551 | ||
| Prevention and control measures | 552 | ||
| Guidelines for the Prevention and Control of Equine Arteritis Virus in Breeding Stallions | 553 | ||
| Guidelines for Breeding a Mare to an Equine Arteritis Virus–Shedding Stallion or Insemination with Equine Arteritis Virus–C ... | 553 | ||
| Guidelines for the Movement of Horses | 554 | ||
| Recent advances in equine arteritis virus research | 554 | ||
| Future directions | 554 | ||
| Acknowledgments | 555 | ||
| References | 555 | ||
| Equine Infectious Anemia in 2014 | 561 | ||
| Key points | 561 | ||
| Introduction | 561 | ||
| Etiology | 562 | ||
| Taxonomy | 562 | ||
| Morphology | 562 | ||
| Equine Infectious Anemia Virus and Its Relationship with Other Lentiviruses | 562 | ||
| Proteins Encoded by Equine Infectious Anemia Virus | 564 | ||
| Gag/Pol | 564 | ||
| Env | 564 | ||
| Accessory proteins | 564 | ||
| Host Cells | 564 | ||
| Mechanisms of Persistence | 564 | ||
| Epidemiology | 565 | ||
| Molecular Epidemiology | 566 | ||
| Intraisolate variation in equine infectious anemia virus | 566 | ||
| Interisolate variation in equine infectious anemia virus | 566 | ||
| Pathogenesis | 567 | ||
| Clinical signs | 568 | ||
| Host immune responses | 568 | ||
| Diagnosis | 569 | ||
| Therapeutic strategies | 570 | ||
| Control strategies | 570 | ||
| Summary | 571 | ||
| References | 572 | ||
| Hendra Virus | 579 | ||
| Key points | 579 | ||
| Emergence | 579 | ||
| Zoonotic infection | 580 | ||
| The viral reservoir | 581 | ||
| Hendra virus infection in horses | 581 | ||
| Pathogenesis and Pathology | 583 | ||
| Laboratory Diagnosis | 584 | ||
| Therapy | 584 | ||
| Community impact | 584 | ||
| A Hendra virus vaccine for horses | 585 | ||
| Postexposure therapeutics for people | 586 | ||
| Other susceptible animal hosts | 586 | ||
| Summary | 587 | ||
| References | 587 | ||
| New Perspectives for the Diagnosis, Control, Treatment, and Prevention of Strangles in Horses | 591 | ||
| Key points | 591 | ||
| Introduction | 591 | ||
| The causal agent | 592 | ||
| Clinical signs of strangles | 592 | ||
| Convalescence and the carrier state | 593 | ||
| Therapeutic treatment of horses with strangles | 593 | ||
| Therapeutic treatment of persistently infected carriers | 594 | ||
| Complications | 595 | ||
| Preventing infection | 595 | ||
| Culture test for Streptococcus equi | 595 | ||
| Polymerase chain reaction assays | 596 | ||
| Serology tests for exposure to Streptococcus equi | 596 | ||
| Using the diagnostic tests to minimize the impact of Streptococcus equi infection | 598 | ||
| Vaccination against strangles | 600 | ||
| Killed and cell extract strangles vaccines | 601 | ||
| Live-attenuated vaccines | 601 | ||
| Subunit vaccines | 602 | ||
| Summary and future perspectives | 603 | ||
| References | 603 | ||
| Rhodococcus equi Foal Pneumonia | 609 | ||
| Key points | 609 | ||
| Introduction | 609 | ||
| Etiology | 609 | ||
| Epidemiology | 609 | ||
| Clinical signs | 612 | ||
| Diagnosis | 612 | ||
| Therapeutic strategies | 614 | ||
| Control strategies | 615 | ||
| Summary | 617 | ||
| References | 617 | ||
| Managing Salmonella in Equine Populations | 623 | ||
| Key points | 623 | ||
| Introduction | 623 | ||
| Importance of Salmonella in equine populations | 624 | ||
| Salmonella: the basics | 624 | ||
| Salmonella testing and interpretation | 625 | ||
| Culture of Fecal Samples | 625 | ||
| Culture of Environmental Samples | 626 | ||
| Polymerase Chain Reaction | 626 | ||
| Lateral Flow Immunoassays | 627 | ||
| Testing Strategy and Test Interpretation | 627 | ||
| Fundamentals of veterinary infection control | 629 | ||
| Managing salmonella risk in hospital populations | 630 | ||
| Patient Management | 630 | ||
| Factors associated with epidemic disease | 630 | ||
| Factors associated with endemic disease | 630 | ||
| Subpopulations and Salmonella Risk | 632 | ||
| Horses with gastrointestinal disease | 632 | ||
| Horses with severe disease | 632 | ||
| Salmonella Surveillance Among Patients in Clinical Practice | 632 | ||
| Management of the Hospital Environment | 634 | ||
| Managing salmonella risk in the field setting | 635 | ||
| Summary | 635 | ||
| References | 635 | ||
| Lawsonia intracellularis and Equine Proliferative Enteropathy | 641 | ||
| Key points | 641 | ||
| Introduction | 641 | ||
| Epidemiology | 642 | ||
| Clinical signs | 643 | ||
| Diagnostic tests | 644 | ||
| Abdominal Ultrasonography | 644 | ||
| Total Protein/Albumin/Clinicopathologic Changes | 644 | ||
| Fecal Polymerase Chain Reaction | 646 | ||
| Serologic Testing | 646 | ||
| Pathology/Pathophysiology | 648 | ||
| Treatment | 648 | ||
| Prevention | 651 | ||
| Monitoring of Herd Status Following Diagnosis of Initial Index Case | 651 | ||
| Monitoring the Herd with Endemic Status | 652 | ||
| Prevention and Vaccination | 653 | ||
| Future directions | 654 | ||
| References | 655 | ||
| Equine Protozoal Myeloencephalitis | 659 | ||
| Key points | 659 | ||
| Introduction | 659 | ||
| Etiologic agents | 660 | ||
| Epidemiology | 660 | ||
| Pathogenesis | 661 | ||
| Experimental Infections | 662 | ||
| Clinical signs | 663 | ||
| Pathology | 664 | ||
| Diagnosis | 664 | ||
| Differential Diagnoses | 665 | ||
| Postmortem Diagnosis | 666 | ||
| Immunodiagnostic Testing | 666 | ||
| Treatment | 667 | ||
| Folate-Inhibiting Drugs | 667 | ||
| Triazines | 668 | ||
| Anti-inflammatory Therapy | 668 | ||
| Biological Response Modifiers | 668 | ||
| Prevention | 669 | ||
| Summary | 669 | ||
| Supplementary data | 670 | ||
| References | 670 | ||
| Equine Piroplasmosis | 677 | ||
| Key points | 677 | ||
| Introduction | 677 | ||
| Etiology | 678 | ||
| Epidemiology | 679 | ||
| Pathogenesis and immunity | 681 | ||
| Clinical signs | 684 | ||
| Diagnosis | 686 | ||
| Therapeutic strategies | 688 | ||
| Control strategies | 689 | ||
| Summary | 689 | ||
| References | 690 | ||
| Infectious Diseases of Working Equids | 695 | ||
| Key points | 695 | ||
| Introduction | 695 | ||
| Infectious diseases of working equids | 696 | ||
| African horse sickness | 696 | ||
| Etiology | 696 | ||
| Epidemiology | 697 | ||
| Clinical Signs and Pathologic Findings | 697 | ||
| Diagnosis | 699 | ||
| Therapeutic Strategies | 699 | ||
| Control Strategies | 700 | ||
| Epizootic lymphangitis | 700 | ||
| Etiology | 701 | ||
| Epidemiology | 701 | ||
| Pathogenesis and Clinical Signs | 701 | ||
| Diagnosis | 701 | ||
| Therapeutic Strategies | 703 | ||
| Control Strategies | 704 | ||
| Equine infectious anemia | 705 | ||
| Etiology | 705 | ||
| Epidemiology | 705 | ||
| Pathogenesis and Clinical Signs | 705 | ||
| Diagnosis | 706 | ||
| Therapeutic and Control Strategies | 706 | ||
| Gastrointestinal nematodes | 706 | ||
| Glanders | 706 | ||
| Etiology | 706 | ||
| Epidemiology and Pathogenesis | 706 | ||
| Clinical Signs | 707 | ||
| Diagnosis | 707 | ||
| Therapeutic Strategies | 707 | ||
| Control Strategies | 707 | ||
| Piroplasmosis | 707 | ||
| Etiology | 707 | ||
| Epidemiology | 708 | ||
| Pathogenesis and Clinical Signs | 708 | ||
| Diagnosis | 708 | ||
| Therapeutic Strategies | 709 | ||
| Control Strategies | 709 | ||
| Tetanus | 709 | ||
| Etiology | 709 | ||
| Epidemiology | 709 | ||
| Pathogenesis and Clinical Signs | 709 | ||
| Diagnosis | 710 | ||
| Index | 719 |